Jefferies Raises Aegerion Pharmaceuticals (AEGR) Target Price After Strong Brazilian Sales
Tweet Send to a Friend
Jefferies maintains their Hold rating on Aegerion Pharmaceuticals (NASDAQ: AEGR) and decided to raise the target price to $26 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
